# Effect of a Ghrelin Receptor Agonist on Muscle and Bone

> **NCT04021706** · PHASE1 · COMPLETED · sponsor: **Tufts University** · enrollment: 32 (actual)

## Conditions studied

- Sarcopenia
- Osteopenia

## Interventions

- **DRUG:** Anamorelin Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04021706
- **Lead sponsor:** Tufts University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-05
- **Primary completion:** 2023-01-26
- **Final completion:** 2023-01-26
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04021706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04021706, "Effect of a Ghrelin Receptor Agonist on Muscle and Bone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04021706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*